Papanicolaou, D A <br/><br/>
A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.  [electronic resource] 

 -  The journal of nutrition, health & aging  2013 
 - 533-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1760-4788 
<br/><br/><label>Standard No.: </label>10.1007/s12603-013-0335-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Aged<br/>Aged, 80 and over<br/>Azasteroids--administration & dosage<br/>Body Composition--drug effects<br/>Dietary Proteins--administration & dosage<br/>Dietary Supplements<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Frail Elderly<br/>Humans<br/>Muscle Strength--drug effects<br/>Muscle, Skeletal--drug effects<br/>Musculoskeletal Physiological Phenomena--drug effects<br/>Receptors, Androgen--drug effects<br/>Sarcopenia--drug therapy<br/>Vitamin D--administration & dosage